Position in PTCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,442,127
+$1,768,802 QoQ
Shares Held
508,056
-12.8% QoQ
Ownership
0.609%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#47
of 380 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. PTCT ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
This page
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in PTCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,442,127 | 508,056 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,673,325 | 582,318 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $21,312,249 | 280,572 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $17,721,630 | 288,767 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $13,099,718 | 268,217 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,976,646 | 274,267 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,402,752 | 208,302 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,728,004 | 208,302 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,369,875 | 208,302 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $806,985 | 27,741 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $803,098 | 29,140 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $653,027 | 29,140 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,185,123 | 29,140 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,411,541 | 29,140 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,109,162 | 186,250 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $865,448 | 17,240 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $632,547 | 15,790 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $429,811 | 11,520 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $398,300 | 10,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $242,832 | 6,526 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $784,869 | 18,568 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $879,194 | 18,568 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,376,484 | 55,325 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,362,762 | 29,150 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $333,564 | 6,574 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $293,266 | 6,574 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||